当前位置:首页 - 行情中心 - 振德医疗(603301) - 财务分析 - 现金流量表

振德医疗

(603301)

  

流通市值:202.34亿  总市值:202.34亿
流通股本:2.64亿   总股本:2.64亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,328,761,588.731,264,024,831.244,524,475,033.793,512,249,649.92
  收到的税费返还118,313,157.7148,784,568.93171,995,823.27146,622,791.23
  收到其他与经营活动有关的现金38,003,063.7222,349,040.7386,954,877.7136,339,188.91
  经营活动现金流入小计2,485,077,810.161,335,158,440.94,783,425,734.773,695,211,630.06
  购买商品、接受劳务支付的现金1,606,069,178.37901,720,485.472,490,239,757.252,047,025,563.82
  支付给职工以及为职工支付的现金531,118,206.21269,609,250.591,006,585,525.37732,829,927
  支付的各项税费160,754,786.1781,917,476.08337,907,070.94313,138,873.62
  支付其他与经营活动有关的现金142,238,083.9876,157,932.23410,204,651.83339,578,064.3
  经营活动现金流出小计2,440,180,254.731,329,405,144.374,244,937,005.393,432,572,428.74
  经营活动产生的现金流量净额44,897,555.435,753,296.53538,488,729.38262,639,201.32
二、投资活动产生的现金流量:
  收回投资收到的现金329,329,338.92140,896,358.52636,835,499.61526,391,517.28
  取得投资收益收到的现金420,449.32-6,309,500-
  处置固定资产、无形资产和其他长期资产收回的现金净额42,618,012.2144,20067,529,017.85628,109.97
  收到的其他与投资活动有关的现金1,396,226.42---
  投资活动现金流入小计373,764,026.86141,040,558.52710,674,017.46527,019,627.25
  购建固定资产、无形资产和其他长期资产支付的现金146,351,156.1180,465,748.77550,215,566.21419,892,275.28
  投资支付的现金251,433,367.6210,370,000657,040,258.4412,040,258.4
  取得子公司及其他营业单位支付的现金--301,053,947.57301,053,947.57
  支付其他与投资活动有关的现金-3,447,990--
  投资活动现金流出小计397,784,523.71294,283,738.771,508,309,772.181,132,986,481.25
  投资活动产生的现金流量净额-24,020,496.85-153,243,180.25-797,635,754.72-605,966,854
三、筹资活动产生的现金流量:
  吸收投资收到的现金2,750,3252,673,393.32702,554.25-
  其中:子公司吸收少数股东投资收到的现金2,750,3252,673,393.32702,554.25-
  取得借款收到的现金886,000,000105,000,0001,636,500,0001,536,500,000
  筹资活动现金流入小计888,750,325107,673,393.321,637,202,554.251,536,500,000
  偿还债务支付的现金845,800,000106,000,000937,700,000707,691,361.11
  分配股利、利润或偿付利息支付的现金97,427,455.875,347,236.48201,493,297.48189,793,055.69
  其中:子公司支付给少数股东的股利、利润2,200,000---
  支付其他与筹资活动有关的现金79,859,145.44,483,700.9553,664,775.4619,328,346.86
  筹资活动现金流出小计1,023,086,601.27115,830,937.431,192,858,072.94916,812,763.66
  筹资活动产生的现金流量净额-134,336,276.27-8,157,544.11444,344,481.31619,687,236.34
四、汇率变动对现金及现金等价物的影响-18,241,185.56-10,686,175.56-13,540,887.78-354,792.69
五、现金及现金等价物净增加额-131,700,403.25-166,333,603.39171,656,568.19276,004,790.97
  加:期初现金及现金等价物余额760,989,683.19760,989,683.19589,333,115589,333,115
  期末现金及现金等价物余额629,289,279.94594,656,079.8760,989,683.19865,337,905.97
补充资料:
  净利润151,050,751.53-267,101,815.58-
  资产减值准备21,588,938.29-33,929,277-
  固定资产和投资性房地产折旧146,091,685.79-268,848,052.17-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧146,091,685.79-268,848,052.17-
  无形资产摊销15,728,778.17-28,530,263.82-
  长期待摊费用摊销1,205,174.82-1,447,939.18-
  处置固定资产、无形资产和其他长期资产的损失8,313,935.18--637,358.48-
  固定资产报废损失169,008.24-2,033,299.97-
  公允价值变动损失-10,690,009.7--634,530.76-
  财务费用29,764,115.09-36,076,014.41-
  投资损失-22,946,175.57--10,458,035.19-
  递延所得税1,418,223.32--1,864,446.99-
  其中:递延所得税资产减少2,143,307.52--445,202.74-
    递延所得税负债增加-725,084.2--1,419,244.25-
  存货的减少-165,963,096.55-1,545,669.93-
  经营性应收项目的减少-63,464,359.98--112,165,962.85-
  经营性应付项目的增加-77,267,455.04-11,629,675.62-
  现金的期末余额629,289,279.94-760,989,683.19-
  减:现金的期初余额760,989,683.19-589,333,115-
  现金及现金等价物的净增加额-131,700,403.25-171,656,568.19-
公告日期2026-08-282026-04-242026-04-242025-10-30
审计意见(境内)标准无保留意见
TOP↑